Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

Leukemia

Volumn 23, Issue 3, 2009, Pages 602-604

  Rohrbacher, M ^a   Berger, U ^a   Hochhaus, A ^a   Metzgeroth, G ^a   Adam, K ^a   Lahaye, T ^a   Saussele, S ^a   Muller M C ^a   Hasford, J ^b   Heimpel, H ^c   Hehlmann, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CHRONIC MYELOID LEUKEMIA; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; GENDER; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOMONOCYTIC LEUKEMIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; QUESTIONNAIRE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 62549108246     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.245     Document Type: Article

References (9)

1. Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia. Lancet 2007; 370: 342-350.
2. McNally RJ, Rowland D, Roman E, Cartwright RA. Age and sex distributions of hematological malignancies in the U. K. Hematol Oncol 1997; 15: 173-189.
3. Krebsregister Saarland, Germany. http://www.krebsregister.saarland.de.
4. Swedish Cancer Registry. 1998-2006, Annual report publications of the Centre of Epidemiology at the National Board of Health and Welfare. http://www.socialstyrelsen.se/Statistik/statistik_amne/Cancer.
5. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ et al. SEER Cancer Statistics Review, 1975-2005. U.S. National Cancer Institute: Bethesda. http://www.seer.cancer.gov/csr/1975_2005/.
6. Harrison SJ, Johnson PRE, Holyoake TL. The Scotland Leukaemia Registry audit of incidence, diagnosis and clinical management of new patients with chronic myeloid leukaemia in 1999 and 2000. Scott Med J 2004; 49: 87-90.
7. Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Reiter A et al. Gender aspects in chronic myeloid leukemia: Long-term results from randomized studies. Leukemia 2005; 19: 984-989.
8. Ridell B, Carneskog J, Wedel H, Vilen L, Hogh Dufva I, Mellqvist UH et al. Incidence of chronic myeloproliferative disorders in the city of Göteborg Sweden 1983-1992. Eur J Haematol 2000; 65: 267-271.
9. Hasford J, Baccarani M, Hehlmann R, Ansari H, Tura S, Zuffa E. Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: A comparative analysis of the Italian German chronic myeloid leukemia trials with interferon-a. Blood 1996; 88: 5384-5391.